Hpv-driven rewiring of the tumor immune microenvironment through single-cell profiling informs prognosis and therapy in HNSCC. Li Y, Kou Q, Zheng C, Nov P, et al. Oral Oncol 2025;172:107789.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li Y, Kou Q, Zheng C, Nov P, et al. Hpv-driven rewiring of the tumor immune microenvironment through single-cell profiling informs prognosis and therapy in HNSCC. Oral Oncol 2025;172:107789.
PMID: 41314067